Of all 301 Vietnamese patients with HER2-positive breast cancer, their average utility score was 0.86, consistent with the results of studies in China, Ethiopia, and India [23, 26, 27, 30] but higher than the findings of a study in Singapore [25]. The gene discussed is ERBB2; the disease is breast carcinoma.